Compare Genuine Parts Company (GPC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Genuine Parts Company trades at $126.99 (market cap $17.67B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Genuine Parts Company is the larger of the two by market cap, and Genuine Parts Company pays a 3.32% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Genuine Parts Company for 75 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GPC | HALO | |
|---|---|---|
Market Cap | $17.67B | $12.58B |
Volume | 1,079,458 | 2,179,278 |
Sector | Consumer Cyclical | Health |
52-Week High | $149.26 | $115.22 |
52-Week Low | $92.47 | $61.63 |
Typical Hold Time | 75 Days | 1 Days |
Enterprise Value | $23.76B | $14.49B |
Dividend Yield | 3.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GPC trades at $127.02, up 1.28% on the day, with a bullish technical signal and analyst consensus price target of $145.75. Recent quarterly earnings show two beats and one miss, while the company prepares for a planned separation of its automotive and industrial units in Q1 2027. Revenue has grown steadily to $24.3B in 2025, but net income margin is thin at 0.13%.
The outlook is supported by the corporate split catalyst and dividend stability, but risks include compressed profitability and rising debt-to-asset ratios. Wall Street sentiment is mixed, with 43% buy ratings, yet the stock offers value with a P/S of 0.71 and exposure to aging vehicle trends.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
